Cyfra 21.1 CEA for both serum and pleural fluid of 168 patients

Malignant pleural effusions (MPEs) are a challenging public health problem, causing significant morbidity and often being the first presenting sign of cancer. Pleural fluid cytology is the most common method used to differentiate malignant from non-malignant effusions. However, its sensitivity reaches 50-70% and depends on the experience of the cytologist, the tumor load, and the amount of fluid tested. Therefore, diagnostic inaccuracy and a high incidence of false negatives may endanger patients with clinical mistreatment and mismanagement.

Dataset Files

You must be an IEEE Dataport Subscriber to access these files. Subscribe now or login.

[1] , "Cyfra 21.1 CEA for both serum and pleural fluid of 168 patients", IEEE Dataport, 2019. [Online]. Available: http://dx.doi.org/10.21227/wk3e-5x64. Accessed: Aug. 20, 2019.
@data{wk3e-5x64-19,
doi = {10.21227/wk3e-5x64},
url = {http://dx.doi.org/10.21227/wk3e-5x64},
author = { },
publisher = {IEEE Dataport},
title = {Cyfra 21.1 CEA for both serum and pleural fluid of 168 patients},
year = {2019} }
TY - DATA
T1 - Cyfra 21.1 CEA for both serum and pleural fluid of 168 patients
AU -
PY - 2019
PB - IEEE Dataport
UR - 10.21227/wk3e-5x64
ER -
. (2019). Cyfra 21.1 CEA for both serum and pleural fluid of 168 patients. IEEE Dataport. http://dx.doi.org/10.21227/wk3e-5x64
, 2019. Cyfra 21.1 CEA for both serum and pleural fluid of 168 patients. Available at: http://dx.doi.org/10.21227/wk3e-5x64.
. (2019). "Cyfra 21.1 CEA for both serum and pleural fluid of 168 patients." Web.
1. . Cyfra 21.1 CEA for both serum and pleural fluid of 168 patients [Internet]. IEEE Dataport; 2019. Available from : http://dx.doi.org/10.21227/wk3e-5x64
. "Cyfra 21.1 CEA for both serum and pleural fluid of 168 patients." doi: 10.21227/wk3e-5x64